Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...

Esophageal Implant MarketThe global esophageal implant market is set for substantial growth, with its valuation projected to reach USD 147 million in 2023. Over the next decade, the market is ...

Connolly, who represents a swath of Northern Virginia, easily won reelection to a ninth term in the House this week.

Sanofi (SNY) has released an update. Sanofi’s Dupixent has received EU approval as the first treatment for children aged one to 11 with ...

Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic ...

I have cancer of the esophagus. It was a surprise because ... I may be a bit fatigued due to the treatment,” he wrote. “I ...

Esophageal Catheters Market. The global esophageal catheters market is poised for significant expansion, with a projected market value of USD 2.2 billion in 2022, and a robust com ...

has been diagnosed with esophageal cancer. Connolly, as reported by The Washington Post, said Thursday morning he will ...

"Cancer can be tough. But so am I," Democratic Rep. Gerry Connolly said. "I will attack this the only way I know how – with ...

Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisApproval based on phase 3 data showing ...

Results from the trial were published in The New England Journal of Medicine.